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Abstract
Normal values provide the background for interpretation of quantitative imaging data and 
thus are essential information for daily routine. Nevertheless, the ways how normal values 
are obtained, presented and interpreted, often do not receive the attention they deserve. 
We review the concepts of normalcy, the implications of typical normal ranges including 
the types of distribution of normal data, the possibilities to index for confounding 
biological factors like body surface area and the limitations of the very concept of normal 
values, demonstrating that there are no easy statistical solutions for difficult clinical 
problems.
Introduction
In echocardiography, as indeed in all cardiac imaging, 
normal values form the foundation for interpreting 
quantitative parameters. This applies to morphologic 
continuous parameters such as linear, area or volume 
measurements (including ventricular mass, which is 
calculated from myocardial volume), as well as Doppler 
or speckle-tracking based blood or tissue velocities and 
derived complex parameters such as strain or strain rate. 
Most laboratories have normal value tables hanging 
at a well visible spot, and compilations of such values 
are among the most often looked up or downloaded 
documents in cardiac imaging (1, 2, 3, 4).
While it seems obvious that we can only identify 
pathologic values if we know the normal range of a 
parameter, it is easy to become overconfident in the 
utility and wisdom of normal values. This applies in 
particular to imagers at the beginning of their learning 
curves or cardiologists whose main focus is not on 
imaging. In the following, we review the rationale and 
practical application of normal values in cardiac imaging 
with respect to underlying assumptions and clinical 
relevance. We focus here on the use of normal values in 
echocardiography, but the same arguments can be made 
for all imaging modalities.
Underlying concepts
Normal individuals
Normal values, by definition, must be gleaned from a 
population of ‘normal’, healthy individuals. Since these, 
again by definition, tend not to undergo cardiac imaging, 
early normal value compilations were derived from studies 
of individuals who appeared to be sufficiently unsuspicious 
of cardiac disease – often laboratory personnel, researchers, 
students and their relatives. Sometimes, these were 
individuals sent to the laboratory for imaging but found 
not to have detectable cardiac disease, such as persons 
with ‘functional’ murmurs, persons undergoing check-ups 
without pathologic findings and others. Note that this, 
strictly speaking, involves a logical circle, since normal 
values are derived from persons deemed to have normal 
findings, which implies that some notion of normalcy 
already exists. Further, such informal criteria result in a 
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clear selection of persons: for example, often volunteers 
are recruited from hospital or academic personnel who 
typically do not represent the age range and other features 
of the general population. Such ‘convenience samples’ of 
individuals cannot be really representative of the general 
(healthy) population, although the latter is the collective 
we ultimately would wish to have as our standard of 
comparison. Nevertheless, many local ‘normal value’ tables 
just reflect such samples, often of only few individuals with 
very limited age range and unbalanced sex distribution. 
Selection bias in the recruitment of participants in a 
normal sample leads to loss of generalizability or ‘external 
validity’: what is true for the biased sample may not be 
true for the general (or a particular) population.
To address this problem, meta-analysis studies have 
been performed utilizing large compilations of normal 
data from diverse populations, ethnicities and age ranges, 
for example the EchoNoRMAL study (5, 6) analyzing data 
from over 22,404 ‘normal’ persons. However, although 
based on person-level data, these data were acquired all 
over the world, with corresponding variability between 
the original readers’ habits and biases. These concerns 
could only be addressed in a future large-scale, prospective 
core-study using a core-laboratory for uniform analysis.
While selection bias can be circumvented by more 
careful though cumbersome recruitment procedures, some 
difficult questions concerning the normalcy of a normal 
collective remain, most importantly: who is really healthy? 
Cardiovascular health is obviously not universally given in 
the general population. For example, about half of the general 
population is expected to develop arterial hypertension 
during their lifetime. Further, the average body mass index 
of the general population deviates considerably from what 
is believed to be ‘healthy’ (i.e., predictive of the longest life 
expectancy). Similar concerns apply for blood lipids and 
blood glucose. Even if we define explicitly the ‘healthy 
controls’ as persons in whom manifest cardiovascular 
disease and risk factors (such as hypertension or obesity) are 
excluded, thorny questions remain. A particularly difficult 
conundrum is age dependency. It seems straightforward 
that there is a decline in exercise capacity with age, but 
this decline can be blunted or halted by physical training. 
For example, diastolic left ventricular function, measured 
invasively or non-invasively, exhibits an age-dependent 
decline, with a well-described age dependency of echo 
parameters of diastolic function. On the other hand, that 
decline is much less in aged persons who continue in a 
highly trained state (7). For a non-cardiac example of a 
nearly universal, age-dependent pathology, osteoporosis 
comes to mind. What is normal, then?
Which populations should be separately tabulated? 
Which parameters should be indexed and how?
Human beings, including healthy individuals, differ by 
height, weight, sex, ethnicity and many other features, for 
example, body fat/lean mass. Ignoring these fundamental 
properties affecting most if not all measurable variables 
may obscure or falsely create pathological measurement 
values. Thus, to the chagrin of cardiac imagers, normal 
values tables went from a simple, all-encompassing 
master table to a multitude of sub-tables allowing for these 
underlying differences, often excused by citing ubiquitous 
digital memory and computing capacity. Publication 
activity has thrived on addressing normal values for 
specific populations, often defined by geographic region. 
Some of the differences found for example between the 
sexes or different ethnicities are quite small, but how 
much is negligible and by what standard?
To account for categorical variables such as sex or 
ethnicity we use separate normal tables for the same 
parameters, e.g. left ventricular volume or mass. Age, 
although a continuous parameter, is also typically categorized 
into age ranges, for which separate normal values are 
established. Furthermore, body size is a major determinant 
of cardiovascular dimensions. This factor is accounted for by 
dividing the parameter by an index of body size, an operation 
called ‘normalizing’, indexing or scaling. For example, left 
ventricular volumes are usually presented as indices (end-
systolic and end-diastolic left ventricular volume index 
or stroke volume index) by dividing by body surface area. 
The rationale is that the division by body surface area will 
remove the dependence of the left ventricular volume on 
individual body size and therefore make it easier to detect 
pathology. However, surprisingly little consensus exists 
which morphological parameters need such ‘normalization’ 
and which index of body size should be used for this. At 
present, linear measures, for example, the left ventricular 
diameters, are not routinely indexed, while volumes, for 
example, chamber volumes, are. Area measurements, such 
as stenotic valvular areas, are sometimes indexed, especially 
if the patient in question is uncommonly small or large. The 
reason for this inhomogeneity is quite simple – given that 
there is an influence of body size on cardiac dimensions, this 
influence will be stronger on volumes, which can be thought 
of as linear measurements to the third power, than on linear 
measurements, and areas (linear measurements to the 
second power) fall in between. An important factor that has 
prevented universal use of indexing is that most literature 
linking measurements (for example, aortic diameters) to 
prognosis is based on un-indexed measurements.
This work is licensed under a Creative Commons 
Attribution-NonCommercial 4.0 International 
License.
www.echorespract.com © 2018 The authors
 Published by Bioscientifica Ltdhttps://doi.org/10.1530/ERP-17-0082
F A Flachskampf and 
P Nihoyannopoulos
Normal values R195:2
For the thorny issue of how to normalize measurements 
to overall body size measures such as surface, height, 
weight and their powers (allometric scaling), we refer to 
the excellent recent overview by Oxborough et al. (6) and 
others (8). In general, it would seem best to normalize in 
a way respecting geometric similarity, i.e., normalizing 
linear measurements to linear body size (height), area 
measurements to for example, surface body area and 
volume or mass measurements to body mass or volume. 
Unfortunately, both body mass and body surface area are 
substantially influenced by obesity (the latter since body 
surface area is calculated from nomograms using body 
height and weight), which in itself should only have 
minor influence of cardiovascular dimensions. Again, 
the ideal solution, normalization for fat-free mass, is 
cumbersome since this parameter is not readily available.
How should normal values be presented?
The simplest way of defining the limits of normalcy is to, 
quite literally, state the upper and lower value limits of a 
parameter in a sample of the normal population: the normal 
range. Since this is obviously very sensitive to the concrete 
normal sample chosen, other standard formulations are 
often used. Most often, it is assumed that the parameter in 
question among the population will follow a Gaussian (‘bell-
shaped’) distribution, indeed a ‘normal distribution’ (Fig. 1). 
In an ideal normal distribution, the interval of 1 standard 
deviation (SD) below and above the mean value will 
comprise 68%, of ±2 SD’s 95%, and of ±3 SD’s 99.7% of all 
values. Habitually, the interval of ±2 SD’s from the mean is 
used as the definition of normalcy for a normally distributed 
continuous variable. While appealing in its simplicity and 
elegance, we need to keep in mind the following limitations:
1. Not all measurements in a normal population follow 
a Gaussian (normal) distribution, and parameters 
can follow a multimodal or skewed distribution. This 
is for example the case for coronary calcifications as 
measured by the Agatston score (9). A more flexible, 
but less convenient way of establishing a normal 
range is referencing quantile cut-offs, for example, the 
range of a parameter excluding the 2.5% or 5% lowest 
or highest values (‘percentiles’) of a normal sample 
and then identifying the range of the remaining data 
points. This type of analysis is entirely independent of 
the actual distribution of the data and does not require 
that it be normally distributed.
2. By the definition of the 95% interval, 5% of a normal 
population would fall into the abnormal (2.5% too 
low or 2.5% too high) ranges. This is a relatively large 
number especially when considering large populations, 
such as the number of healthy individuals seen at a 
busy echo laboratory. For a given parameter, say, left 
ventricular end-diastolic diameter, we can expect that 
5 in 100 truly ‘normal’ individuals would be falsely 
labeled as abnormal if one follows this definition. 
Further, since we evaluate more than one parameter in 
each echo exam, the consequences are even more dire. 
If we evaluate 20 quantitative parameters per study 
(and if they are normally distributed in the healthy 
population), and use 95% intervals as normal ranges 
for these parameters, we would ‘in the long run’ obtain 
on average one falsely pathologic measurement in each 
healthy patient we examine, even if our measurements 
are perfect, just by the definition of the 95% interval. 
Therefore, in practice, clinical uncertainty persists at 
the borders of such normalcy ranges. Of course, one 
could use instead ±1 SD, thus excluding in the long 
run 32% of true normals, or ±3 SD’s, which is nearly 
identical with the normal range, but thus does not 
provide a ‘security margin’ against pathological values.
Handling mean and SD can be simplified by using Z-scores, 
which have gained popularity in particular in pediatric 
cardiology, where rapidly and substantially changing 
Figure 1
Example graph of a normally distributed variable. The x-axis displays the 
cumulative probability in percent of the variable values, which are shown 
on the y-axis. All values (cumulative probability of 100%) lie under the 
bell-shaped curve. Fifty percent of values are lower and 50% are higher 
than the mean value (mean and median of a normal distribution are the 
same). The SD describes the breadth of the curve. The intervals 
corresponding to ±1, ±2, and ±3 SD’s (SD, or Z-scores; red horizontal 
double arrows), encompass 68, 95, and 99.7 of all values, respectively.
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body sizes in infants and adolescents must be dealt with 
(10). Z-scores are based on mean value and SD of a given 
parameter, which can be indexed to a variable such as 
body surface area, height or powers of such variables (11). 
The formula for the Z-score of a particular measurement 
x is Z-score = (x − xmean)/SD, where xmean is the mean value 
and SD is the standard deviation of that parameter in a 
population of normals of that age and/or body size. A 
Z-score of 1 is the interval from xmean to xmean + 1 SD, etc. 95% 
of normal values thus fall within Z-scores of ±2. Besides the 
assumption of a normal distribution of the values, there is 
also the underlying assumption of ‘homoscedasticity’ (or 
absence of heteroscedasticity), which means that variance 
itself should be independent of the absolute values of 
the variable under consideration. This is often not the 
case in reality: for example, in a study of normal values 
for Doppler variables in children, variance increased with 
age (12). Another important limitation of Z-scores is that 
calculation mostly requires access to a computer.
Thus, the presentation of normal values should 
contain a precise definition of the measurement protocol 
(e.g. left atrial area by biplane Simpson’s rule). If data 
are normally distributed they should be described by 
mean and SD, after stratifying or indexing for factors 
with proven independent influence, such as age, sex, 
ethnicity, measures of body size, etc. The limit here is 
how complex and extensive the data are allowed to be 
presented. Variability can instead be described in terms 
of Z-scores. If data are not normally distributed, the most 
straightforward manner is to present them as medians 
with quantiles, for example, quartiles or percentiles.
The challenge of different modalities 
and techniques
Imaging parameters can be obtained by different imaging 
modalities. This regularly leads to systematic differences 
in values for the same parameter, for example, for cardiac 
chamber volumes including left ventricular volumes. For 
a number of reasons, cardiac chamber volumes measured 
by magnetic resonance are substantially larger than by 
echocardiography, and cardiac computed tomography 
volumes are again larger than magnetic resonance 
volumes (13). These differences are systematic, i.e., not 
due to errors but inherent to methodology, and ultimately 
irreconcilable.
Furthermore, within one modality there often exist 
several ways or protocols to measure certain parameters. 
In echocardiography, for example, left atrial size can be 
measured in at least 5 ways:
 • as a linear antero-posterior diameter in the parasternal 
long-axis view;
 • as an area, usually in the apical four-chamber view;
 • as a volume using an area-length method (monoplane 
or biplane);
 • as a volume using Simpson’s rule (monoplane or 
biplane);
 • as a volume using 3D echo;
each of these methods giving (slightly) different results.
Thus, clearly, claiming that one modality is superior 
to another is rather absurd as each is using different 
techniques for measuring the same thing, whether 
by using ultrasound reflections (echo), proton spins 
(magnetic resonance imaging) or positron-electron 
collisions (positron emission tomography); however, 
none of them is closer to the ‘real heart’ than the other.
Finally, technical issues such as hardware and software 
from different manufacturers (or even different product 
generations from the same manufacturer) may introduce 
non-negligible measurement variability. An important 
example of this is the well-appreciated manufacturer 
dependency of echocardiographic strain calculations.
While some of the cited differences have to be 
acknowledged as systematic, unavoidable biases 
necessitating separate sets of normal values, it is 
nevertheless important to avoid comparing apples 
and pears by unifying measurement conventions and 
protocols. The lack of such unified conventions has been 
particularly evident in the basic and simple measurement 
of diameters of the ascending aorta. Practically all 
conventions have been recommended at some point by 
some professional society, from inner-edge to inner-edge 
to outer-edge to outer-edge and from systolic to diastolic 
measurement (14, 15). Predictably, different measurement 
protocols will lead to artificial measurement discrepancies, 
further leading to confusion and potentially adverse 
management decisions. Occasionally, cut-offs used and 
validated in studies may influence the definitions of 
normalcy and abnormality. Clearly, more cooperative 
effort for standardization across modalities is necessary 
here for the benefit of patients and imagers alike.
Conclusion
Normal values are indispensable, yet, problematic. 
They appear to provide certainty where often in reality 
we cannot be sure. While the literature presents an 
increasingly complex body of tabulated data, one should 
be aware of the fundamental limitations of the notion and 
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notation of normal values. Difficult clinical judgments 
(e.g., interpretation of an aortic diameter in a very small 
or very large person) are not easily solved by normal 
value compilations. We should use normal values with 
caution and understand them not as normative, but as an 
orientation. Furthermore, more collaborative efforts are 
needed to harmonize and unify measurement protocols 
and conventions across imaging modalities but accepting 
the inherent differences for each modality.
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